Header Logo

Connection

MICHAEL YEN to Botulinum Toxins

Back to Details
This is a "connection" page, showing publications MICHAEL YEN has written about Botulinum Toxins.
MICHAEL YEN
Connection Strength
2.601
Botulinum Toxins
  1. Polytetrafluoroethylene frontalis suspension in blepharospasm with eyelid apraxia: an effective and well-tolerated adjunct to botulinum toxin therapy. Orbit. 2021 Feb; 40(1):39-43.
    View in: PubMed
    Score: 0.605
  2. Developments in the treatment of benign essential blepharospasm. Curr Opin Ophthalmol. 2018 Sep; 29(5):440-444.
    View in: PubMed
    Score: 0.544
  3. Blepharospasm and Hemifacial Spasm. Int Ophthalmol Clin. 2018; 58(1):1.
    View in: PubMed
    Score: 0.519
  4. Secondary Blepharospasm Associated With Ocular Surface Disease. Int Ophthalmol Clin. 2018; 58(1):71-75.
    View in: PubMed
    Score: 0.519
  5. Update on botulinum toxins in oculofacial plastic surgery. Int Ophthalmol Clin. 2013; 53(3):21-31.
    View in: PubMed
    Score: 0.367
  6. Orbicularis oculi muscle graft augmentation after protractor myectomy in blepharospasm. Ophthalmic Plast Reconstr Surg. 2003 Jul; 19(4):287-96.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.